Omar Khan | Hamad Bin Khalifa University

Dr. Omar Khan

Assistant Professor

Phone

44548052

Office location

B141, 1st Floor, LAS Building, HBKU

Dr. Omar Khan

Assistant Professor

Educational Qualifications

Ph.D. in Molecular Medicine with Prof. Martin Bergo

MSc in Molecular Cell Biology

Entity

College of Health and Life Sciences

Biography

Dr. Khan did his Masters in Biochemistry from Karachi University, Pakistan before moving to Sweden. In Sweden, he did Masters in Cell Biology from Uppsala University, and then a Ph.D. in the lab of Prof. Martin Bergo, a protein lipidation expert. In Bergo's lab, he identified the biochemical importance of protein lipidation enzyme GGTase-I in immune cell function and refuted the popular idea that GGTase-I can be a therapeutic target against inflammatory conditions. After finishing his Ph.D., he moved to The Francis Crick Institute in Dr. Axel Behrens Lab, where he worked on identifying the posttranslational regulators of a tumour suppressor protein FBW7 and mechanisms of chemotherapy resistance in cancer.

 

Ph.D. in Molecular Medicine with Prof. Martin Bergo

Sahlgrenska Cancer Center Gothenburg University, Sweden

2007 – 2012

MSc in Molecular Cell Biology

Uppsala University, Sweden

2005 – 2006

MSc in Biochemistry

University of Karachi, Pakistan

2002 – 2003

Honorary Teaching Assistant

King’s College London, United Kindom

2018

Postdoctoral fellow with Dr. Axel Behrens

The Francis Crick Institute, United Kingdom

2013 - 2018

Postdoc with Prof. Martin Bergo

Sweden

2012

  • J Clin Invest. Feb 2018. (IF: 12.78)

    Omar M. Khan, Joana Carvalho, Bradley Spencer-Dene, Richard Mitter, David Frith, Bram Snijders, Stephen A. Wood, and Axel Behrens

  • Circ Res. 2014 Oct 10;115(9):781-9. (IF: 13.96)

    Sayin VI, Khan OM, Pehlivanoglu LE, Staffas A, Ibrahim MX, Asplund A, Agren P, Nilton A, Bergström G, Bergo MO, Borén J, Lindahl P.

  • Circulation Feb 2013. (IF: 19.3)

    Khan OM, Akula MK, Skålen K, Karlsson C, Ståhlman M, Young SJ, Boren J and Bergo MO.

  • J Clin Invest. 2011 Feb 1;121(2):628–39. (IF: 12.78)

    Khan OM, Ibrahim MX, Jonsson IM, Karlsson C, Liu M, Sjogren AKM, Olofsson FJ, Brisslert M, Andersson S, Ohlsson C, Hultén LM, Bokarewa M, and Bergo MO.

  • Leukemia 2010 Oct 26. (IF: 11.7)

    Sjogren AK, Andersson KM, Khan O, Olofsson FJ, Karlsson C, Bergo MO.

  • Mol. Oncol. 2008 Jun;2(1):94–101.(IF: 5.33)

    Linda Strandberg Ihrlund, Emma Hernlund, Omar Khan, Maria C. Shoshan

  • July 2014–June 2017, VetenskapsRådet (VR) international postdoctoral fellow in molecular biology from Gothenburg University, Sweden. (Avtals ID: D0035901, 3.1 million SEK for 3-years)
  • July 2013–June 2014, European Molecular Biology Organization’s (EMBO) postdoctoral fellow. (ID: ALTF 459-2013, GBP 28738 for 24-months; second year turned down)